Skip to content

Clinical trials

Lung Diseases trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Not applicable Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20182
20191
20204
20231
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Unknown status4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital2
The Second Hospital of Shandong University2
China-Japan Friendship Hospital1
Chinese PLA General Hospital1
Fujian Medical University Union Hospital1
Guangzhou Institute of Respiratory Disease1
Olympus Corporation of the Americas1
Peking Union Medical College Hospital1
Peking University Third Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases15
Lung Neoplasms2
Pulmonary Disease, Chronic Obstructive2
Respiratory Tract Diseases2
Emphysema1
Neoplasms1
Neoplasms by Site1
Pathologic Processes1
Pneumonia1
Postoperative Pain1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.